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The phenomenon of conditioned taste aversion (CTA) is generated after ingestion of a specific food is associated with an adverse outcome, i.e., sickness. In this issue of Neuron, Chen et al. (2018) interrogate the pivotal role of PBN CGRP neurons in both the acquisition and the expression of CTA.
I know buffalo chicken wings are good. Not only are they tasty, but they once triggered feelings of camaraderie and joy as my friends and I watched another Boston sports franchise win yet another championship. Despite these sentiments, I no longer partake in buffalo chicken consumption as my strongest memory of eating this food is linked to the norovirus I somehow contracted hours before a weekly ''10-cent wings night.'' Despite knowing that the incurring sickness was completely independent of the food I just ate, I haven't touched buffalo chicken wings in a decade. This particular episode of conditioned taste aversion (CTA) describes an experience the majority of us have shared throughout our lives; however, the neural underpinnings responsible for encoding these associations and persistent memories remain poorly understood. In this issue of Neuron, Chen et al. demonstrate the instrumental role of calcitonin gene-related peptide (CGRP) neurons in the parabrachial nucleus (PBN) in gating both the acquisition and the expression of CTA (Chen et al., 2018) . Learning to distinguish whether certain food is safe for ingestion is critical for survival across the animal kingdom. One of the mechanisms by which animals learn to avoid harmful substrates is known as CTA, a classical Pavlovian conditioning paradigm, where the once non-salient, consumed food (conditioned stimulus; CS) becomes correlated with an aversive outcome such as sickness (unconditioned stimulus; US). From then on, the CS alone is capable of evoking the US, and this negative association can last a lifetime. As with all memories, learning to pair the tastant to the adverse experience comprises the acquisition phase while recalling the event is the expression phase of CTA.
Recent work has pinpointed PBN CGRP neurons at the center of governing various forms of danger including noxious cutaneous stimuli such as shock, heat, and itch, visceral stimuli like lipopolysaccharide, or novel food substrates (Palmiter, 2018) .
In order to test the relative contribution of the neuropeptide CGRP in CTA acquisition, Chen et al. (2018) neurons in CTA are compatible with their anatomical pre-and postsynaptic partners. Information originating from the tongue papillae and the viscera transmit through the geniculate and vagal ganglia, respectively, to the nucleus of the solitary tract (NTS). The NTS projects to the PBN, where this information is relayed to the gustatory cortex, thalamus, hypothalamus, and the amygdala. In mammals, decerebration experiments demonstrated that forebrain areas are critical for acquiring CTA (Grill and Norgren, 1978) . Concordantly, high-frequency, optogenetic terminal activation of PBN CGRP / CeA or PBN CGRP /BNST projections promoted CTA and reduced food intake. However, stimulation of PBN CGRP efferents in the gustatory thalamus were unable to elicit CTA. Thus, despite the homogeneity in cellular response properties , these findings raise the possibility that PBN CGRP cells are a mixed population with disparate functional and anatomical projections with at least partial redundancy. Previously, it was shown that CGRP receptor (Calcrl)-expressing neurons in the CeA were postsynaptic to PBN CGRP neurons, acting to relay US processing during threat conditioning in fear learning protocols. Whether this same CeA Calcrl population is involved in CTA acquisition, expression, or both remains to be discovered. Given the spinal, visceral (via NTS), and forebrain afferent inputs to PBN CGRP neurons (Tokita et al., 2009) . Recently, the Food and Drug Administration has approved a new class of migraine drugs (Aimovig) aimed to fight painful and nausea-inducing migraine headaches before they start. Perhaps not surprisingly, CGRP is the major target of these novel pharmaceuticals. It remains to be seen whether deep neuroscience explorations into the encoding properties of PBN CGRP neurons in response to harmful agents can guide the development of future pharmacological approaches, but it seems to be on the right track. Imagine a world in which drugs could be guided toward specific PBN CGRP circuits and subtypes to combat eating, pain, and/or anxiety disorders. Designer treatments tailor made for each individual's affliction constructed around one common, molecular target. Although this may be forward thinking, in retrospect, I wish I had access to some anti-CGRP pills that night years ago so that I could still enjoy buffalo chicken wings to this day as I continue to celebrate accumulating Boston sports championships. 
